From: A multiplex platform for the identification of ovarian cancer biomarkers
Protein | Late versus healthy | |||
---|---|---|---|---|
AUC (95% CI) | Rank | Sensitivity at 95% specificity (95% CI) | Rank | |
CA.125 | 1 (1, 1) | 1 | 1 (1, 1) | 1 |
HE4 | 1 (0.99, 1) | 2 | 0.99 (0.94, 1) | 2 |
MK | 0.98 (0.94, 1) | 3 | 0.91 (0.79, 0.99) | 3 |
KLK6 | 0.95 (0.9, 0.99) | 4 | 0.88 (0.8, 0.96) | 4 |
hK11 | 0.93 (0.88, 0.98) | 5 | 0.79 (0.63, 0.93) | 6 |
FR.alpha | 0.92 (0.83, 0.98) | 6 | 0.81 (0.67, 0.94) | 5 |
CXCL13 | 0.92 (0.85, 0.97) | 7 | 0.66 (0.43, 0.87) | 7 |
IL.6 | 0.89 (0.8, 0.97) | 8 | 0.59 (0.26, 0.85) | 10 |
PDGF.subunit.B | 0.87 (0.77, 0.95) | 9 | 0.42 (0.2, 0.76) | 19 |
U.PAR | 0.86 (0.75, 0.95) | 10 | 0.39 (0.12, 0.77) | 23 |
FADD | 0.84 (0.74, 0.93) | 11 | 0.59 (0.36, 0.81) | 9 |
TNFSF14 | 0.84 (0.72, 0.94) | 12 | 0.38 (0.17, 0.71) | 29 |
IL.7 | 0.84 (0.72, 0.93) | 13 | 0.46 (0.25, 0.7) | 16 |
CSF.1 | 0.84 (0.7, 0.95) | 14 | 0.28 (0.04, 0.74) | 39 |
CD40.L | 0.83 (0.72, 0.95) | 15 | 0.22 (0.02, 0.82) | 53 |
TGF.alpha | 0.83 (0.71, 0.93) | 16 | 0.38 (0.14, 0.72) | 30 |
PRSS8 | 0.83 (0.71, 0.93) | 17 | 0.49 (0.3, 0.74) | 15 |
MMP.1 | 0.82 (0.69, 0.92) | 18 | 0.26 (0.08, 0.58) | 47 |
FUR | 0.82 (0.7, 0.92) | 19 | 0.28 (0.09, 0.62) | 40 |
TNF.R1 | 0.82 (0.69, 0.93) | 20 | 0.44 (0.22, 0.72) | 18 |
ILT.3 | 0.81 (0.67, 0.92) | 21 | 0.39 (0.15, 0.68) | 28 |
SCF | 0.81 (0.72, 0.89) | 22 | 0.64 (0.46, 0.8) | 8 |
NTRK3 | 0.8 (0.67, 0.9) | 23 | 0.53 (0.25, 0.76) | 11 |
HGF | 0.8 (0.66, 0.92) | 24 | 0.38 (0.14, 0.67) | 32 |
HB.EGF | 0.8 (0.65, 0.93) | 25 | 0.27 (0.06, 0.65) | 42 |